相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIV-1 Infection of Female Genital Tract Tissue for Use in Prevention Studies
Charlene S. Dezzutti et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Adherence Support Approaches in Biomedical HIV Prevention Trials: Experiences, Insights and Future Directions from Four Multisite Prevention Trials
K. Rivet Amico et al.
AIDS AND BEHAVIOR (2013)
Nonreproducibility of Snap-Frozen Rectal Biopsies for Later Use in Ex Vivo Explant Infectibility Studies
Ian McGowan et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Safe and Sustained Vaginal Delivery of Pyrimidinedione HIV-1 Inhibitors from Polyurethane Intravaginal Rings
Todd J. Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load
Victor G. Kramer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection
Pedro M. M. Mesquita et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Seminal Fluid Induces Leukocyte Recruitment and Cytokine and Chemokine mRNA Expression in the Human Cervix after Coitus
David J. Sharkey et al.
JOURNAL OF IMMUNOLOGY (2012)
Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
Michael C. Thigpen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
J. M. Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Preexposure Prophylaxis for HIV Infection among African Women
Lut Van Damme et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Microbicides: Topical Prevention against HIV
Robin J. Shattock et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Quantification of interactions between drug leads and serum proteins by use of binding efficiency
Sofia S. Gustafsson et al.
ANALYTICAL BIOCHEMISTRY (2011)
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection
Peter L. Anderson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial
Sheena McCormack et al.
LANCET (2010)
Coexistence of passive and carrier-mediated processes in drug transport
Kiyohiko Sugano et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Robert M. Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical Trials
Marla J. Keller et al.
PLOS ONE (2010)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim et al.
SCIENCE (2010)
Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women
Annalene A. Nel et al.
AIDS (2009)
Safety and Pharmacokinetics of Dapivirine Delivery From Matrix and Reservoir Intravaginal Rings to HIV-Negative Women
Annalene Nel et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates
Nattawan Promadej-Lanier et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2009)
Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1
Kavita M. Gupta et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine model
Pedro M. M. Mesquita et al.
JOURNAL OF VIROLOGY (2008)
Seminal plasma reduces the effectiveness of topical polyanionic microbicides
Sarju Patel et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections
Rebecca Pellett Madan et al.
JOURNAL OF VIROLOGY (2007)
HIV-1 subtypes: epidemiology and significance fov HIV management
AM Geretti
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
P Dorr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Clinical development of microbicides for the prevention of HIV infection
OJ D'Cruz et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Topical microbicides for disease prevention: Status and challenges
PF Harrison et al.
CLINICAL INFECTIOUS DISEASES (2003)
Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides
P Greenhead et al.
JOURNAL OF VIROLOGY (2000)
分享论文
